Summary

Dr. Paolo Tarantino shares insights into the latest breast cancer consensus guidelines, with a focus on the evolving role of ADCs and how to move beyond the guidelines in clinical decision-making. Dr. Nathaniel Bouganim leads a comparative analysis with Canadian practices, exploring how global recommendations can be adapted to real-world oncology care.

Recorded from the LIVE webinar on May 27, 2025.

This activity has been funded by an educational grant from AstraZeneca and Daiichi Sankyo and is intended for healthcare practitioners only.

Highlights

  • 1

    Explore the Dana-Farber Breast Cancer Consensus and its key clinical considerations.

  • 2

    Compare international and Canadian guidelines, including the REAL Alliance recommendations.

  • 3

    Evaluate challenges and opportunities in adapting global breast cancer recommendations to the Canadian healthcare landscape.

User

Dr. Nathaniel Bouganim, MD

Assistant Professor, Oncology, McGill University Health Centre

User

Dr. Paolo Tarantino, MD

Clinical Research Fellow Dana-Farber Cancer Institute

Comments (0)